Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation (CDMO) business with a ₹192.5 crore (CHF 20 million) acquisition of Swiss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback